Clinical Trial Detail

NCT ID NCT02713373
Title Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute

colorectal cancer


Cetuximab + Pembrolizumab

Age Groups: adult

Additional content available in CKB BOOST